News

September 20, 2018September 20, 2018

29 Young Researchers to Share $6M Prostate Cancer Foundation Grant

News

A $6 million Prostate Cancer Foundation (PCF) grant will help 29 early-career researchers find better ways to detect and treat prostate cancer, and ultimately a cure, the find a ... Read more

September 19, 2018

Study Examines Erleada Add-on for Non-metastatic Castration-resistant Prostate Cancer

News

Patients with castration-resistant prostate cancer (CRPC) who are at high risk for developing metastasis may safely add Erleada (apalutamide) to androgen deprivation therapy without worrying about their quality of life, ... Read more

September 17, 2018

Androgen Deprivation Therapy Can Make Prostate Cancer More Aggressive, Study Finds

News

While androgen deprivation therapy (ADT) is an important treatment for prostate cancer, a new study has found that it sometimes promotes the transformation of prostate cancer cells into a more ... Read more

September 13, 2018

A.I.-guided Chemo Halts Disease Worsening in Patient with mPRPC, Study Reports

News

An artificial intelligence (A.I.) platform called CURATE.AI may be used to determine the optimal doses of investigational therapy ZEN-3694 and Xtandi (enzalutamide) to be given to patients with metastatic castration-resistant ... Read more

September 12, 2018

Sex and Intimacy After Prostate Cancer Focus of Sept. 29 Webinar

News

Us TOO International will present a free webcast on Sept. 29 aimed at providing prostate cancer patients and their partners suggestions on how to improve and maintain sexual intimacy. ... Read more

September 10, 2018September 10, 2018

Patient Death in Phase 2b Prostate Cancer Trial Unrelated to Topsalysin, Sophiris Says

News

Topsalysin (PRX302), an investigative agent for localized prostate cancer, is unlikely to have caused the death of a patient in a Phase 2b trial testing the medicine, Sophiris Bio announced. A review of ... Read more

September 6, 2018

Focal Therapy With Ultrasound for Prostate Cancer Effective, Causes Few Side Effects, Study Suggests

News

Focal therapy with high-intensity focused ultrasound is effective in the medium term and rarely causes urinary or rectal side effects in patients with clinically significant localized prostate cancer, a large, ... Read more

September 5, 2018

Higher Radiotherapy Doses But Fewer Treatment Sessions May Be Possible, Early Trial Data Suggest

News

Prostate cancer patients may benefit from a new form of radiation therapy that delivers larger doses per session but in a much shorter treatment course, and when used in ... Read more

August 16, 2018

Low Protein Intake During Pregnancy Raises Progeny’s Risk of Future Prostate Cancer, Rat Study Finds

News

Consumption of a low-protein diet during pregnancy and breastfeeding may increase the risk of male offspring developing prostate cancer later in life, a rat study suggests. The study, “Maternal Low-Protein Diet ... Read more

August 13, 2018August 14, 2018

3 in 4 Men with Slow-growing Prostate Cancer Fail to Get Appropriate Follow-up, Study Finds

News

Nearly three-quarters of men with slow-growing prostate cancer who decide on active surveillance are not receiving the appropriate follow-up and might be missing signs of tumor worsening, according to a ... Read more